Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06532708 · ClinicalTrials.gov registry record · NA
Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
A NA study of Postoperative Pain and Opioid Use, sponsored by University of Tennessee.
- Recruiting
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT06532708: Recruiting NA study of Postoperative Pain and Opioid Use, sponsored by University of Tennessee.
NCT06532708 is a NA study of Postoperative Pain and Opioid Use that is actively recruiting participants, run by University of Tennessee. The registered enrollment target is 12 participants, below the 232-participant average among 120 other Postoperative Pain trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06532708, a NA study of Postoperative Pain and Opioid Use, is actively recruiting participants, sponsored by University of Tennessee.
- RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare opioid prescribing practices by either routine provider prescribing practices, or with the use of a calculator, i.e., the Opioid Calculator, published by the University of Michigan (www.opioidcalculator.org), with the intent of decreasing the number of pills.
Conditions Studied
Interventions
- OTHER 5x Oxycodone Oral Tablets
- OTHER 16x Oxycodone Oral Tablets
Study Locations (1)
Tennessee
- University of Tennessee Health Science Center - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2024-07-12 |
| Est. Completion | 2024-10-31 |
| Phase | NA |
What NCT06532708 shows while recruiting
NCT06532708 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 232-participant average among 120 other Postoperative Pain trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Postoperative Pain appearing as the primary indexed condition, and to 2 interventions - of which 5x Oxycodone Oral Tablets is the first listed.
NCT06532708 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT06532708 about?
NCT06532708 is a clinical study titled "Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery". The purpose of this study is to compare opioid prescribing practices by either routine provider prescribing practices, or with the use of a calculator, i.e., the Opioid Calculator, published by the University of Michigan (www.opioidcalculator.org), with the intent of decreasing the number of pills.
What is the current status of trial NCT06532708?
This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2024-07-12. Estimated completion is 2024-10-31.
What conditions does trial NCT06532708 study?
This clinical trial studies the following conditions: Postoperative Pain, Opioid Use.
What interventions are being tested in trial NCT06532708?
The interventions under investigation include: 5x Oxycodone Oral Tablets (OTHER), 16x Oxycodone Oral Tablets (OTHER).
Who is sponsoring clinical trial NCT06532708?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06532708 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06532708's enrollment target sits among peer trials
12 119th of 120 higher than 2 of 120 other Postoperative Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postoperative Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Virtual Reality and Olfactory Stimuli Multimodal Intervention to Reduce Post-Operative Pain and Anxiety in Patients Undergoing Cardiothoracic Surgery
RECRUITING · NA
-
Rectus Sheath Block in Cardiac Surgery
RECRUITING · NA
-
Pain With Differing Insufflation Pressures During Laparoscopic Hysterectomy
RECRUITING · NA
-
Effects of Assisted Robotic vs Laparoscopic Sleeve Gastrectomy
RECRUITING · NA
-
Postoperative Pain Control in AIS Using Liposomal Bupivacaine vs. 0.25% Bupivacaine With Epinephrine
RECRUITING · NA
-
QL vs LAI for Palatoplasty
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI